Compound Danshen Dripping Pill for Diabetic Microvascular Angina

Summary

To investigate the efficacy and safety of Compound Danshen Dripping Pill in patients with diabetic microvascular angina pectoris. Long-term follow-up of 1 year will be performed to evaluate the effect of Compound Danshen Dripping Pill on coronary flow reserve and adverse cardiovascular events in patients with coronary microvascular disease.

Timeline

Start

2025-01-01

Primary completion

2026-12-31

Completion

2027-06-30

Drugs

Indications